Sectoral Asset Management Inc Savara Inc Transaction History

Sectoral Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$0.71 - $4.91 $504,320 - $3.49 Million	-710,310 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$2.16 - $3.2 $66,506 - $98,528	-30,790 Reduced 4.15%	710,310 $1.88 Million
Q2 2019 Aug 14, 2019	SELL	$2.37 - $11.7 $367,587 - $1.81 Million	-155,100 Reduced 17.31%	741,100 $1.76 Million
Q1 2019 May 14, 2019	BUY	$6.71 - $8.6 $333,487 - $427,420	49,700 Added 5.87%	896,200 $6.61 Million
Q4 2018 Feb 12, 2019	BUY	$6.27 - $10.92 $250,799 - $436,800	40,000 Added 4.96%	846,500 $6.41 Million
Q3 2018 Nov 14, 2018	BUY	$10.49 - $12.87 $4.98 Million - $6.11 Million	475,000 Added 143.29%	806,500 $9 Million
Q2 2018 Aug 13, 2018	BUY	$8.55 - $13.76 $500,175 - $804,960	58,500 Added 21.43%	331,500 $3.75 Million
Q1 2018 May 15, 2018	BUY	$8.99 - $14.95 $1.02 Million - $1.69 Million	113,000 Added 70.63%	273,000 $2.51 Million
Q4 2017 Feb 13, 2018	BUY	$8.26 - $16.76 $1.32 Million - $2.68 Million	160,000	160,000 $2.37 Million

133

151M

67.6K

29.4K

Ticker SVRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,043,000
Market Cap $318M
Description
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.